OpportunityTitle: Developmental Psychopharmacology (R21)
AdditionalInformationOnEligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Description: -Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to request research applications to examine the neurobiological impact of psychotherapeutic medications upon the immature brain, with particular emphasis upon mapping the precise developmental profile of physiological response to psychotropic agents used in the treatment of mental disorders in children. Appropriate research includes studies in model systems, including animals, and in human populations. -Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with an FOA of identical scientific scope, PA-07-084, that solicits applications under the R01 mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon availability of funds and the submission of a sufficient number of meritorious applications.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster &lt;br/&gt;FBOWebmaster@OD.NIH.GOV &lt;br/&gt;
CloseDateExplanation: Multiple Receipt Dates - See Link to Full Announcement for details.